In this study, we determined the mechanism underlying the ability of Daxx to suppress hypoxia-induced lung cancer metastasis, showing that Daxx acts through the HIF-1α/HDAC1/Slug pathway (Fig. 8b). Here, HDAC1 is linked to lung carcinoma.